This powerful, multi-modal action is why the triple agonist is considered one of the most significant advances in metabolic medicine for both obesity and Type 2 Diabetes
Prioritizing regular sleep routines and exploring stress-reduction techniques such as meditation, yoga, or deep breathing can make a positive difference
In a phase 2 study in people with obesity (without T2D), retatrutide (doses 1 to 12 mg) has led to a dose-dependent WL up to 24.2% at the end of the 48-week treatment period compared to 2.1% with placebo [81]
Some people taking GLP-1 medications may experience digestive side effects, with these being the most common: Nausea, especially at the start or after a dose increase Heartburn or stomach discomfort after meals Constipation, which can occur as the body adjusts Diarrhea, which may be mild or bothersome Vomiting, sometimes along with nausea Most digestive side effects lessen as the body adjusts
When regulators challenged the ability to market and supply the offer at scale, investors repriced the entire upside of weight loss rather than just one SKU
